SEC Form 4 · accession 0001209191-15-072226
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hani M Zeini
Director
Period of report
Sep 23, 2015
Accepted (ET)
Sep 25, 2015 · 7:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.28 | Sep 23, 2015 | A | 10,179 | A | — | Sep 23, 2025 | Common Stock | 10,179 | 10,179 | D |
Explanation of responses
- F1Option shares vest in 12 equal quarterly installments measured from the vesting commencement date, September 23, 2015.